According to a new study, some drugs marketed for memory and brain power improvement contain extremely high levels of an unapproved drug.
In several brain stimulation supplements, also known as “nootropics,” researchers found the unapproved drug called piracetam waiting. Currently approved as a recruiting drug in Europe, piracetam is not approved for all conditions and can, according to a new survey published on 25 November in the JAMA Internal Medicine, create a slew of psychological side effects, including anxiety, depression, and insomnia.
Currently approved as a recruiting drug in Europe, piracetam is not approved for all conditions and can, according to a new survey published on 25 November in the JAMA Internal Medicine, create a slew of psychological side effects, including anxiety, depression, and insomnia.
Nootropics and other dietary supplements, unlike pharmaceutical drugs, will not undergo a difficult approval process before they are placed on the market according to the USA. Administration of Food and Drugs (FDA). The FDA classifies supplements as food, not medicines, a technique that allows supplement manufacturers to sell their goods without first proving safe and efficient.
The group has identified 14 brain-enhancing supplements with piracetam. The researchers limited their analysis to the 5 remaining brands, so there were two companies unavailable for purchase, and 7 brands were not clearly showing the words “dietary supplement”
You found that there were no piracetams in a supplement and, depending on the batch, the other four products contained different amounts of the medication. The actual amount of piracetam for these four labels ranged from 85% to 118% of the amount indicated on the bottle.
Piracetam emerged in 1971 as the first nootropic medication to be used on the American drug market to enhance cognitive function without sedating or calming the US consumer. National Medical Library. Today, in Europe physicians mostly prescribe the medicine to treat unwanted muscle spasms, but also prescribe off-label drugs in order to alleviate learning difficulties for children. Piracetam is used in older adults to improve their memory and to reduce the symptoms of dementia.
So piracetam fails in two respects as an ingredient of U.S. supplements: the drug itself is not approved, and at best its alleged benefits are anecdotal. The FDA has recently warned of the possible risks of nootropics in general but Cohen claimed that no concrete action has been taken against piracetam supplementary companies.